These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 25285790)
1. Factors associated with hospital length of stay among cancer patients with febrile neutropenia. Rosa RG; Goldani LZ PLoS One; 2014; 9(10):e108969. PubMed ID: 25285790 [TBL] [Abstract][Full Text] [Related]
2. Time to antibiotics and outcomes in cancer patients with febrile neutropenia. Perron T; Emara M; Ahmed S BMC Health Serv Res; 2014 Apr; 14():162. PubMed ID: 24716604 [TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections and inpatient length of stay among pediatric cancer patients with febrile neutropenia in Mexico City. Avilés-Robles M; Ojha RP; González M; Ojeda-Diezbarroso K; Dorantes-Acosta E; Jackson BE; Johnson KM; Caniza MA Am J Infect Control; 2014 Nov; 42(11):1235-7. PubMed ID: 25234044 [TBL] [Abstract][Full Text] [Related]
4. Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center. Nguyen M; Jacobson T; Torres J; Wann A Cancer Rep (Hoboken); 2021 Jun; 4(3):e1345. PubMed ID: 33635593 [TBL] [Abstract][Full Text] [Related]
5. Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia. Daniels LM; Durani U; Barreto JN; O'Horo JC; Siddiqui MA; Park JG; Tosh PK Support Care Cancer; 2019 Nov; 27(11):4171-4177. PubMed ID: 30805726 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of febrile neutropenia in pediatric cancer patients in Jordan. Al Omar S; Nazer L; Alkayed K J Pediatr Hematol Oncol; 2013 Nov; 35(8):614-7. PubMed ID: 23823118 [TBL] [Abstract][Full Text] [Related]
7. Malnourishment and length of hospital stay among paediatric cancer patients with febrile neutropaenia: a developing country perspective. Conner JM; Aviles-Robles MJ; Asdahl PH; Zhang FF; Ojha RP BMJ Support Palliat Care; 2016 Sep; 6(3):338-43. PubMed ID: 27267224 [TBL] [Abstract][Full Text] [Related]
8. [Post chemoterapy febrile neutropenia. Length of stay and experience in our population]. Pérez-Heras Í; Raynero-Mellado RC; Díaz-Merchán R; Domínguez-Pinilla N An Pediatr (Engl Ed); 2020 Mar; 92(3):141-146. PubMed ID: 31239190 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for multidrug-resistant bacteremia in hospitalized cancer patients with febrile neutropenia: a cohort study. Rosa RG; Goldani LZ; dos Santos RP Am J Infect Control; 2014 Jan; 42(1):74-6. PubMed ID: 24210467 [TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of clinical acuity markers on hospital length of stay in patients with febrile neutropenia. Johannesmeyer HJ; Seifert CF J Oncol Pharm Pract; 2019 Apr; 25(3):535-543. PubMed ID: 29207937 [TBL] [Abstract][Full Text] [Related]
11. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis. Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Microbiologically-documented Infections, Mortality and Prolonged Hospital Stay in Children with Febrile Neutropenia. Das A; Trehan A; Bansal D Indian Pediatr; 2018 Oct; 55(10):859-864. PubMed ID: 29941699 [TBL] [Abstract][Full Text] [Related]
13. Pediatric Oncology Discharges With Febrile Neutropenia: Variation in Location of Care. Alvarez E; Chamberlain LJ; Aftandilian C; Saynina O; Wise P J Pediatr Hematol Oncol; 2017 Jan; 39(1):e1-e7. PubMed ID: 27918351 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department. Pascual C; Trenchs V; Hernández-Bou S; Català A; Valls AF; Luaces C Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1667-72. PubMed ID: 27319003 [TBL] [Abstract][Full Text] [Related]
15. [Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database]. Freyer G; Scotte F; Borget I; Bruyas A; Vainchtock A; Chouaid C Bull Cancer; 2016 Jun; 103(6):552-60. PubMed ID: 27233367 [TBL] [Abstract][Full Text] [Related]
16. Trends in Incidence and Outcomes of Clostridium difficile Colitis in Hospitalized Patients of Febrile Neutropenia: A Nationwide Analysis. Siddiqui NS; Khan Z; Khan MS; Khan Z; Haq KF; Solanki SD; Munigala S; Khan MA; Saif MW; Nawras A J Clin Gastroenterol; 2019 Oct; 53(9):e376-e381. PubMed ID: 30614941 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Different Doses of Granulocyte Colony-stimulating Factor in the Treatment of High-risk Febrile Neutropenia in Children With Cancer. Ok ZO; Kupeli S; Sezgin G; Bayram I J Pediatr Hematol Oncol; 2020 Nov; 42(8):e738-e744. PubMed ID: 32925403 [TBL] [Abstract][Full Text] [Related]
18. The utility of routine chest radiography in the initial evaluation of adult patients with febrile neutropenia patients undergoing HSCT. Yolin-Raley DS; Dagogo-Jack I; Niell HB; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker BE J Natl Compr Canc Netw; 2015 Feb; 13(2):184-9. PubMed ID: 25691611 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review. Lyman GH; Abella E; Pettengell R Crit Rev Oncol Hematol; 2014 Jun; 90(3):190-9. PubMed ID: 24434034 [TBL] [Abstract][Full Text] [Related]
20. A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. Parodi RL; Lagrutta M; Tortolo M; Navall E; Rodríguez MS; Sasia GF; De Candia LF; Gruvman MA; Bottasso O; Greca AA PLoS One; 2019; 14(10):e0224299. PubMed ID: 31671108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]